WBC-reduced blood transfusions and clinical outcome in children with acute lymphoid leukemia

Transfusion

Volumn 41, Issue 7, 2001, Pages 873-877

  Rios, Jorge A ^a   Korones, David N ^a   Heal, Joanna M ^a   Blumberg, Neil ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ALLOGRAFT; ARTICLE; BACTERIUM CULTURE; BLOOD TRANSFUSION; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD;

BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; LEUKAPHERESIS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE;

EID: 0034933372     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41070873.x     Document Type: Article

References (14)

1. Leukocyte reduction in blood component therapy
2. Allogeneic transfusion and infection-economic and clinical implications
3. The transfusion immunomodulation theory - The Th1/Th2 paradigm and an analogy with pregnancy as a unifying mechanism
4. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery
5. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery
6. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery
7. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery
8. Impact of leukocyte-depleted blood components on the haematological recovery and prognosis of patients with acute myeloid leukaemia
9. Leukodepleted-ABO-identical blood components in the treatment of hematologic malignancies: A cost analysis
10. Leukocyte-reduced transfusions of ABO-identical platelets and clinical outcome in autologous bone marrow transplantation for lymphoma
11. Reduced morbidity and mortality in acute leukemia associated with leukodepleted blood transfusions
12. Transfusions and risk of failure in childhood acute lymphoblastic leukemia
13. Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: A report from the Taiwan Pediatric Oncology Group
14. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia